17-alpha-hydroxyprogesterone and Breast Cancer

17-alpha-hydroxyprogesterone has been researched along with Breast Cancer in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (40.00)	18.7374
1990's	6 (40.00)	18.2507
2000's	2 (13.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (6.67)	2.80

Authors

Authors	Studies
Kar, SP; Nounu, A; Relton, CL; Richmond, RC	1
Day, NE; Dowsett, M; Dunning, AM; Easton, DF; Folkerd, E; Healey, CS; Kelemen, L; Luben, RN; Novik, KL; Ogata, S; Pharoah, PD; Ponder, BA; Tee, L	1
Lelle, I; Prifti, S; Rabe, T; Strowitzki, T	1
Bodrogi, L; Fehér, T; Ribai, Z; Vallent, K	1
Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE	1
Carella, MJ; Dimitrov, NV; Gossain, VV; Rovner, DR; Srivastava, L	1
Bucciante, G; Maggino, T; Pirrone, F; Velluti, F	1
Castilla, JA; Herruzo, A; Marcos, C; Menjón, S; Ramírez, A	1
Demers, LM; Garber, JE; Hanagan, J; Harvey, H; Henderson, IC; Lipton, A; Lynch, J; Mulagha, M; Navari, RM; Santen, RJ	1
Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A	1
Bennet, A; Caron, P; Carton, M; Gorguet, B; Martel, P; Roche, H	1
Bonfrer, JM; Bruning, PF; de Jong-Bakker, M; Hart, AA; Moolenaar, AJ; Nooijen, WJ; van der Linden, E	1
Cantwell, BM; Dowsett, M; Harris, AL	1
Doorenbos, H; Sleijfer, DT; Sluiter, WJ; van der Ploeg, E; van Veelen, H; Willemse, PH	1
Freidenberg, GR; Horwitz, KB	1

Trials

2 trial(s) available for 17-alpha-hydroxyprogesterone and Breast Cancer

Article	Year
Adrenal effects of low-dose aminoglutethimide when used alone in postmenopausal women with advanced breast cancer. Metabolism: clinical and experimental, 1994, Volume: 43, Issue:6 Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Aged; Aldosterone; Aminoglutethimide; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Middle Aged; Postmenopause; Progesterone	1994
Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer. European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:2 Topics: 17-alpha-Hydroxyprogesterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Drug Evaluation; Estradiol; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged; Receptors, Estrogen	1989

Article

Year

Adrenal effects of low-dose aminoglutethimide when used alone in postmenopausal women with advanced breast cancer.

Metabolism: clinical and experimental, 1994, Volume: 43, Issue:6

Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Aged; Aldosterone; Aminoglutethimide; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Middle Aged; Postmenopause; Progesterone

1994

Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer.

European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:2

Topics: 17-alpha-Hydroxyprogesterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Drug Evaluation; Estradiol; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged; Receptors, Estrogen

1989

Other Studies

13 other study(ies) available for 17-alpha-hydroxyprogesterone and Breast Cancer

Article	Year
Sex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study. Breast cancer research : BCR, 2022, 10-08, Volume: 24, Issue:1 Topics: 17-alpha-Hydroxyprogesterone; Adult; Aldosterone; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Estradiol; Female; Genome-Wide Association Study; Gonadal Steroid Hormones; Humans; Hydrocortisone; Longitudinal Studies; Mendelian Randomization Analysis; Progesterone; Sex Hormone-Binding Globulin; Testosterone	2022
Polymorphisms associated with circulating sex hormone levels in postmenopausal women. Journal of the National Cancer Institute, 2004, Jun-16, Volume: 96, Issue:12 Topics: 17-alpha-Hydroxyprogesterone; Aged; Androstenedione; Aromatase; Aryl Hydrocarbon Hydroxylases; Breast Neoplasms; Case-Control Studies; Catechol O-Methyltransferase; Cytochrome P-450 CYP1B1; England; Estradiol; Estrone; Female; Genetic Predisposition to Disease; Genetic Variation; Genotype; Gonadal Steroid Hormones; Humans; Linear Models; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Postmenopause; Sex Hormone-Binding Globulin; Steroid 17-alpha-Hydroxylase; Testosterone	2004
Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 19, Issue:1 Topics: 17-alpha-Hydroxyprogesterone; Breast Neoplasms; Contraceptives, Oral, Combined; Dihydrotestosterone; Drug Combinations; Ethisterone; Genetic Vectors; Humans; Luciferases; Norgestrel; Oximes; Receptors, Androgen; Testosterone; Transfection; Tumor Cells, Cultured	2004
Role of human adipose tissue in the production and metabolism of steroid hormones. Endokrinologie, 1982, Volume: 80, Issue:2 Topics: 17-alpha-Hydroxyprogesterone; Adipose Tissue; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Estrogens; Female; Gonadal Steroid Hormones; Humans; Hydrocortisone; Hydroxyprogesterones; Male; Obesity; Progesterone; Radioimmunoassay; Testosterone	1982
Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer. British journal of cancer, 1983, Volume: 47, Issue:5 Topics: 17-alpha-Hydroxyprogesterone; Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Cosyntropin; Dehydroepiandrosterone; Drug Administration Schedule; Drug Therapy, Combination; Estrone; Female; Hormones; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged	1983
The role of the endocrine factors and obesity in hormone-dependent gynecological neoplasias. European journal of gynaecological oncology, 1993, Volume: 14, Issue:2 Topics: 17-alpha-Hydroxyprogesterone; Adipose Tissue; Aged; Androgens; Body Mass Index; Body Weight; Breast Neoplasms; Endometrial Neoplasms; Estradiol; Female; Hormones; Humans; Hydroxyprogesterones; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Obesity; Pyrones; Regression Analysis; Risk Factors; Sex Hormone-Binding Globulin	1993
Tumour necrosis factor-alpha and interleukin-1 and -6 in fibrocystic breast disease. Breast cancer research and treatment, 1999, Volume: 54, Issue:2 Topics: 17-alpha-Hydroxyprogesterone; Adult; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Estradiol; Exudates and Transudates; Female; Fibrocystic Breast Disease; Humans; Interleukin-1; Interleukin-8; Middle Aged; Potassium; Regression Analysis; Risk Assessment; Risk Factors; Sodium; Testosterone; Tumor Necrosis Factor-alpha	1999
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor. The Journal of clinical endocrinology and metabolism, 1991, Volume: 73, Issue:1 Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrone; Fadrozole; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Imidazoles; Kinetics; Menopause; Nitriles	1991
Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:7 Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged; Thyroxine; Triiodothyronine	1991
Mammary ovarian metastases with stroma cell hyperplasia and postmenopausal virilization. Cancer, 1990, Sep-15, Volume: 66, Issue:6 Topics: 17-alpha-Hydroxyprogesterone; Breast Neoplasms; Carcinoma; Female; Humans; Hydroxyprogesterones; Hyperplasia; Menopause; Middle Aged; Muscle, Smooth; Ovarian Neoplasms; Ovary; Receptors, Estradiol; Receptors, Progesterone; Testosterone; Virilism	1990
High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer. British journal of cancer, 1988, Volume: 58, Issue:4 Topics: 17-alpha-Hydroxyprogesterone; Aged; Aged, 80 and over; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Ketoconazole; Menopause; Middle Aged; Sex Hormone-Binding Globulin; Testosterone	1988
Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients. Cancer chemotherapy and pharmacology, 1985, Volume: 15, Issue:2 Topics: 17-alpha-Hydroxyprogesterone; Adrenal Insufficiency; Aged; Androstenedione; Breast Neoplasms; Cosyntropin; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Metyrapone; Middle Aged	1985
Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies. Cancer research, 1985, Volume: 45, Issue:1 Topics: 17-alpha-Hydroxyprogesterone; Androgens; Breast Neoplasms; Calcitriol; Cell Division; Cell Line; Dexamethasone; DNA, Neoplasm; Drug Resistance; Estradiol; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Kinetics; Norpregnadienes; Promegestone; Receptor, Insulin; Receptors, Progesterone	1985